Frank J. Rybicki received his PhD in Medical Engineering from MIT in 1995. He chairs the Department of Radiology, Banner University Medical Group, and the University of Arizona - Phoenix. Dr. Rybicki founded the RSNA 3D Printing Special Interest Group. He launched and is Editor-in-Chief of 3D Printing in Medicine (3D Print Med), 2022 IF = 3.7. Dr. Rybicki edited the most widely sold book on medical 3D printing. The second edition of this book 3D Printing at Hospitals and Medical Centers: A Practical Guide for Medical Professionals will be released in January 2024.

Professor Clara Chow is Academic Director of the Westmead Applied Research Centre (WARC), Faculty of Medicine and Health, University of Sydney. She is a cardiologist and Clinical Lead of Community Based Cardiac Services at Westmead Hospital and is also a member of the Western Sydney Local Health District (WSLHD) Governing Board, Sydney, Australia. Professor Chow is Director of the Australian Stroke and Heart Accelerator (ASHRA). Her recent award highlights include being a finalist for the NSW Premier’s Woman of the Year - Woman of Excellence Category - in 2024 and 2020 respectively, receiving a Research Australia Digital Health Technology – Highly Commended Award, becoming an Honour of Australia recipient as well as a Fellow of the AAHMS in 2023 and being honoured with a Telstra Health - Brilliant Woman in Digital Health Award in 2022. She holds an honorary appointment as the Charles Perkins Centre Westmead Academic Co-director and is past-President of the Cardiac Society of Australia and New Zealand. Professor Chow’s research focuses on the prevention of cardiovascular disease, innovation in the delivery of cardiovascular care and the evaluation of digital health interventions. She has expertise in the design, delivery and implementation of clinical trials. Her PhD from the University of Sydney, Australia was in cardiovascular epidemiology and international public Health and her Postdoc from McMaster University, Canada in clinical trials and cardiac imaging. She has over 250 publications including papers in internationally leading medical journals NEJM, JAMA and Lancet. She is supported by a NHMRC Investigator grant.

Jae K. Oh, M.D., is a consultant in the Department of Cardiovascular Medicine at Mayo Clinic in Rochester. He currently serves as director of the Echocardiography Core Laboratory. He is also director of the Pericardial Clinic and co-director of Integrated Cardiac Imaging. Dr. Oh is recognized with the distinction of a named professorship, the Samsung Professorship in Cardiovascular Diseases. He has been working with the Samsung Medical Center for Samsung-Mayo Collaboration and is the Founding General Director of Heart Vascular Stroke Institute at Samsung Hospital in Seoul, Korea. Dr. Oh earned his B.S. degree in biochemistry with honors at the University of Pennsylvania, and his M.D. degree at Pennsylvania State University. He completed a residency in internal medicine, with an outstanding achievement award, and a fellowship in cardiovascular diseases, both at Mayo Clinic College of Medicine. Dr. Oh has research interest in all aspects of echocardiography and its use in clinical trials as well as in clinical diagnoses. His research focuses on diastolic function, heart failure related to diastolic dysfunction, valvular heart diseases, pericardial diseases, and artificial intelligence using ECG and Echocardiography. He has established noninvasive Mayo Clinic diagnostic criteria for constrictive pericarditis and the concept of transient constriction. Dr. Oh is also passionate about pursuing multimodality imaging in cardiovascular diseases. He is frequently invited to give presentations on his research both domestically and internationally and has authored over 500 manuscripts. He has published 4 editions of “The Echo Manual” which has become a standard textbook for echocardiography. In recognition of his work, Dr. Oh has received many awards and honors, including the Cardiovascular Teacher of the Year for several years and Most Outstanding Mentor Award in Internal Medicine, conferred by Mayo Clinic, and named Lectureships (the William Gaash Lecture, Euro Echo Lecture, Edler Lecture at the EACVI, Echo Seoul, HB Callejo 1st Memorial Lecture in Philippine) Dr. Oh has received the Lifetime Achievement Award from the European Society of Cardiology Myocardial-Pericardial working group and the 10th Lifetime Achievement Award from the American Society of Echocardiography in June of 2019.

Gemma is a Professor in Medicine at the University of Sydney and an Interventional Cardiologist at Royal North Shore Hospital in Sydney. She is the Chair of the University of Sydney’s multi-disciplinary Cardiovascular Initiative. Gemma is committed to improving the care for heart attack patients, unravelling key mechanisms underlying susceptibility and response to heart attack, with studies extending from the bench to large cohort studies and clinical trials. Discoveries in her Laboratory have been published in leading journals including the Lancet, Circulation, JACC and European Heart Journal, with > 250 publications. Gemma is a principal investigator on grants >$26 Mill. Her discoveries and innovative strategies have resulted in a US patent, and 5 provisional patents spanning diagnostic and therapeutic fields. Gemma is founder and CSO for Australian start-ups Prokardia and Kardiomics, and the not-for-profit CAD Frontiers Pty Ltd. She was awarded a National Health and Medical Research Council (NHMRC) Excellence Award for Top Ranked Practitioner Fellow (Australia- 2018), NSW Ministerial Award for Cardiovascular Research Excellence (2019) and was the second female to be awarded the prestigious Cardiac Society of Australia and New Zealand RT Hall Prize for outstanding and sustained research achievement (2023). Gemma serves as a member of the Editorial Board of leading international journals including Circulation and Cardiovascular Research and an Associate Editor for Heart, Lung and Circulation. She is a passionate advocate for cardiovascular research, working as President of the Australian Cardiovascular Alliance with a national team to secure $220 Million Federal funding for the Mission for Cardiovascular Health, and to build new pathways for research to best serve the unmet health needs of Australians. She chairs the MRFF Mission (CV) Expert Advisory Panel. She is a graduate of the Australian Institute of Company Directors and serves/has served as a non-executive Director on multiple community Boards, including the Heart Foundation. In 2023, Gemma was appointed a Member of the Order of Australia (AM), in the Australia Day Honours.

Stephen Lewin is a Cardiology Trainee based at Sir Charles Gairdner Hospital in Western Australia. His interests are in valvular heart disease and medicolegal matters.

Professor Girish Dwivedi, MD, DM, MRCP (UK), PhD (UK), FESC, FASE, FSCCT, FCSANZ, is the inaugural Wesfarmers Chair in Cardiology at the Harry Perkins Institute of Medical Research, University of Western Australia (UWA), and Consultant Cardiologist at Fiona Stanley Hospital, Murdoch, Perth. He leads the "Advanced Clinical and Translational Cardiovascular Imaging" group at the Harry Perkins Institute of Medical Research (University of Western Australia) and also holds the position of Joint Head of the Cardiovascular Disease and Diabetes Program at Perkins, as well as serving as the Director of the Cardiometabolic Clinic at the Centre for Cardiometabolic Health and Research, Fiona Stanley Hospital. He has >250 manuscripts accepted or published. Several of his original research manuscripts have been published in top-tier journals such as Annals of Internal Medicine, JACC, Circulation, JACC-Imaging, and Circulation Heart Failure. He has written chapters in a highly prestigious book in Cardiology (Principles and Practice of Clinical Cardiovascular Genetics published by Oxford University Press). His group has conducted pioneering work examining the association of inflammation and atherosclerosis. He has utilized a trans-disciplinary approach that involves translational medicine and novel cardiovascular imaging methods in assessing subclinical atherosclerosis in distinct inflammatory clinical phenotypes. This body of work has received many grants and generated several publications in high-impact journals such as Annals of Internal Medicine, Chest, Journal of Nuclear Cardiology, and AJP-Heart and Circulatory Physiology. After arriving in Perth, he has collaborated closely with the Computer Science colleagues at UWA. Dr. Dwivedi started working with a MedTech start-up company based in Perth (Artrya Ltd) soon after its inception as the Chief Medical Officer and as Chief Scientific Officer (since 2021). Their joint research program is focused on the development of artificial intelligence algorithms to automate advanced and novel cardiac CT biomarker assessment towards heart disease events. Dr. Dwivedi contributed to the development of the intellectual property, resulting in a TGA approved product.

Abdul Ihdayhid is a Structural Interventional Cardiologist and Cardiac CT Specialist at Fiona Stanley Hospital, as well as the Director of Cardiology Research. Abdul undertook interventional fellowships at Monash Heart, Monash Medical Centre and a post-doctoral fellowship at the St Paul’s Hospital in Canada, in advanced cardiac imaging and structural heart intervention. He completed his PhD in intracoronary physiology and cardiac CT at Monash University.